June 15, 2020

    Qorvo Biotechnologies is developing a point-of-care (POC) diagnostic testing platform that aims to change how healthcare is provided. Our developmental system is based on high performance bulk acoustic wave (BAW) detection, designed with the goal to provide accurate, central lab equivalent results within 10-15 minutes.